Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Form N-CSR Lincoln Bain Capital For: Mar 31
-
Form N-CEN Lincoln Bain Capital For: Mar 31
-
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
-
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
-
Lerner & Rowe Accelerates Settlements by Up to Three Months and Increases Policy-Limit Recoveries
-
Form N-23C3A Lincoln Bain Capital For: Jun 02
-
Rocket Software Named as a Challenger in the 2026 Gartner® Magic Quadrant™ for Technical Debt Management Tools
-
Bain Capital Launches JB Aircraft Finance, LLC in Partnership with Aviation Experts to Provide Flexible Corporate Jet Financing Solutions
-
As Financial Services Moves from AI Pilots to AI Operations, Brillio Appoints Jeff McMillan as Independent Director
-
Blackstone raises $13.1 billion for its largest Asia private equity fund
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Form D/A Bain Capital Insurance
-
Kedrion Biopharma and InstaLILY Convene Industry Leaders to Advance the Future of AI in Healthcare at NY Tech Week
-
/C O R R E C T I O N -- Kedrion Biopharma/
-
Form 8-K Bain Capital Private For: May 29
-
UPDATE - Titan Aircraft Investments Completes Sale of Boeing 767-300ERF to Cargo Aircraft Management, Inc.
-
Titan Aircraft Investments Completes Sale of Boeing 767-300ERF to Cargo Aircraft Management, Inc.
-
Form D/A Bain Capital Structured
-
BURLINGTON STORES REPORTS STRONG FIRST QUARTER SALES AND EARNINGS GROWTH, WELL AHEAD OF GUIDANCE. THIS REPRESENTS THE 14TH CONSECUTIVE QUARTER OF DOUBLE DIGIT EPS GROWTH.
-
BRP REPORTS FISCAL YEAR 2027 FIRST QUARTER RESULTS
-
Sensorium Therapeutics to Present SNTX-2643 Mechanistic Data and Phase 1a Study Design at ASCP 2026
-
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
-
Cogent Research: Exploits Outpace Scanner Detection for 62% of Critical Vulnerabilities as AI Compresses Time-to-Exploit to Under 12 Hours
-
Norm Law Launches Emerging Companies and Venture Capital Practice with Senior Additions from Pillsbury and Bain Capital Ventures
-
Cogent Launches Zero Day Response and Autonomous Remediation, Closing the Gap Between Vulnerability Disclosure and Confirmed Fix
-
Bain Capital and 11North Partners Acquire Five Open-Air Retail Centers for $300 Million
-
Form 8-K Bain Capital Private For: May 21
-
Form 4 RAPID MICRO BIOSYSTEMS, For: May 20 Filed by: Bain Capital Life Sciences Investors, LLC
-
KGS Law Group Recovers Policy Limits in 90% of Cases Without Concessions and Cuts Deposition Prep Time by 96%
-
Form 8-K Bain Capital Specialty For: May 21
-
Form 8-K Bain Capital Private For: May 21
-
Variational Secures ~$50M to Bring Liquidity from Traditional Markets To Crypto
-
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
-
VXI Receives Frost & Sullivan's 2026 North America Company of the Year for Excellence in Revenue Generating Solutions Leadership
-
Google DeepMind hires staff from Contextual AI in licensing deal, source says
-
Norm Law Adds Veteran Corporate Transactions Partner James Gerkis
-
GraniteShares Expands Autocallable ETF Lineup with Launch of PLTR and HOOD ETFs
-
Rapid Micro Biosystems prices $9.8 million stock and warrant offering
-
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
-
Form SCHEDULE 13G/A Lincoln Bain Capital Filed by: LVIP GLOBAL GROWTH ALLOCATION MANAGED RISK FUND
-
Form SCHEDULE 13D/A Lincoln Bain Capital Filed by: LINCOLN NATIONAL CORP
-
Form 4 Lincoln Bain Capital For: May 14 Filed by: Lincoln Financial Investments Corp
-
ADGM Strengthens Position as MEASA's Leading IFC With 57% Growth in AUM, over 13,000 Active Licences in Q1 2026
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
